Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Study of DSXS in Moderate to Severe Scalp Psoriasis
NCT02933528Phase 2Completed
- Start
- Jul 2016
- Primary completion
- Aug 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of desoximetasone in psoriasis. Primary endpoint: Proportion of Patients in the Study With HPA Axis Suppression at 28 days. Started Jul 2016; status: completed.
02
Drugs
desoximetasone
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT02933528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02933528.